Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04000373 · ClinicalTrials.gov registry record · NA
Pilot Study of Powered Exoskeleton Use for Gait Rehabilitation in Individuals With Multiple Sclerosis
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT04000373 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 5 participants.
The verdict
NCT04000373, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The investigator plans to test the use of the Ekso Bionics® Gait Training (Ekso GT™) exoskeleton for gait training in MS patients. The device will solely be used in the clinic under direct supervision from a physical therapist. This is a small PI-initiated uncontrolled pilot study to gather safety and feasibility data on the exoskeleton in individuals with MS and walking impairment.
Interventions
- DEVICE Ekso GT™ exoskeleton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2019-07-23 |
| Est. Completion | 2020-01-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04000373
The ClinicalTrials.gov registry entry for NCT04000373 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ekso GT™ exoskeleton is the first listed.
NCT04000373 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04000373 about?
NCT04000373 is a clinical study titled "Pilot Study of Powered Exoskeleton Use for Gait Rehabilitation in Individuals With Multiple Sclerosis". The investigator plans to test the use of the Ekso Bionics® Gait Training (Ekso GT™) exoskeleton for gait training in MS patients. The device will solely be used in the clinic under direct supervision from a physical therapist. This is a small PI-initiated uncontrolled pilot study to gather safety a...
What is the current status of trial NCT04000373?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2019-07-23. Estimated completion is 2020-01-09.
What interventions are being tested in trial NCT04000373?
The interventions under investigation include: Ekso GT™ exoskeleton (DEVICE).
Who is sponsoring clinical trial NCT04000373?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.